Stay updated on Botensilimab in Metastatic Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page.

Latest updates to the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page
- CheckyesterdayChange DetectedA minor update to the ClinicalTrials.gov page’s revision/version indicator is shown (v3.5.2 → v3.5.3). This reflects a platform or release change rather than a change to the underlying trial record.SummaryDifference0.1%

- Check8 days agoChange DetectedRevision 3.5.2 was added to the history and Revision 3.5.0 was removed.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedAdded site revision v3.5.0 and removed revision v3.4.3.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the study history. This is an update to the page’s version history rather than to the trial data or content.SummaryDifference0.1%

- Check73 days agoChange DetectedVersion history shows a new revision v3.4.2 added and revision v3.4.1 removed, reflecting administrative updates to the record rather than changes to trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check80 days agoChange DetectedThe history table shows a new revision entry (v3.4.1) and removal of v3.4.0 as part of administrative versioning updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Botensilimab in Metastatic Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Botensilimab in Metastatic Pancreatic Cancer Clinical Trial page.